These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Inhaler technology: new concepts for the millennium. Woolcock AJ Postgrad Med; 1999 Dec; 106(7 Suppl):18-21. PubMed ID: 19667497 [TBL] [Abstract][Full Text] [Related]
29. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease. Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934 [TBL] [Abstract][Full Text] [Related]
30. [Surfactant therapy in the complex treatment of children with acute lung injury]. Bagaev VG; Amcheslavskiĭ VG; Gorokhov DV Anesteziol Reanimatol; 2009; (1):72-3. PubMed ID: 19348334 [No Abstract] [Full Text] [Related]
31. Exogenous surfactant administration during the transport of premature infants. Riek KM Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930 [No Abstract] [Full Text] [Related]
32. Immediate respiratory management of the preterm infant. Sinha SK; Gupta S; Donn SM Semin Fetal Neonatal Med; 2008 Feb; 13(1):24-9. PubMed ID: 17981103 [TBL] [Abstract][Full Text] [Related]
33. Clinical and laboratory studies of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in bronchopulmonary diseases. Fumagalli G; Mazzola C; Chierichetti S Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:274-8. PubMed ID: 5067204 [No Abstract] [Full Text] [Related]
34. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems. Tayab ZR; Hochhaus G Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772 [TBL] [Abstract][Full Text] [Related]
36. [Analysis of maintenance therapy in hospitalized patients with exacerbation of bronchial asthma: a six-year observation]. Sereda VP; Svistov AS Klin Med (Mosk); 2005; 83(12):36-41. PubMed ID: 16502722 [TBL] [Abstract][Full Text] [Related]
37. The use of aerosol medication in respiratory disease. Gonda I Aust Fam Physician; 1992 May; 21(5):575-6. PubMed ID: 1520126 [No Abstract] [Full Text] [Related]
38. Inhaled efficacious dose translation from rodent to human: A retrospective analysis of clinical standards for respiratory diseases. Phillips JE Pharmacol Ther; 2017 Oct; 178():141-147. PubMed ID: 28442326 [TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients. Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060 [TBL] [Abstract][Full Text] [Related]
40. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term. Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]